In the last five years, a growing body of research has identified PADI1 and its involvement in multiple cancers including pancreatic ductal adenocarcinoma, colorectal cancer, nasopharyngeal carcinoma and several squamous cell carcinomas [77–81]. Here, PADI1 is linked to pancreatic ductal adenocarcinoma.